Company profile: CHEORS
1.1 - Company Overview
Company description
- Provider of health economics and outcomes research services, including development, review, and quality assurance of health economic models, early decision models, country adaptations for HTA submissions, systematic literature reviews, meta-analyses, and database analyses, plus market-access planning and tailored payer tools to support reimbursement and access decisions.
Products and services
- Health Economic Models: Engineers HTA-compliant models that quantify long-term health and economic impact of medical technologies, with country adaptations for HTA submissions, guiding clinical decisions and reimbursement determinations
- Early Decision Models: Architects early-stage models using limited evidence to explore scenarios that inform strategic planning, support clinical trial design, and shape pricing strategies during product development
- Customized Payer Tools: Constructs custom-engineered tools tailored for payers that support decision-making processes in healthcare reimbursement and access, aiding market-access planning and payer support
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CHEORS
Siegfried
HQ: Switzerland
Website
- Description: Provider of contract development and manufacturing for active pharmaceutical ingredients and drug products, including intermediates and controlled substances. Services span process development and optimization, formulation and pilot-scale production, registration support, and packaging and logistics for tablets, capsules, sterile vials, ampoules, cartridges, and ointments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Siegfried company profile →
Clinical Trial Data
HQ: United States
Website
- Description: Provider of data management, biostatistical, and medical writing services for pharmaceutical companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinical Trial Data company profile →
Trillium Health Care Products
HQ: Canada
Website
- Description: Provider of contract manufacturing, formulation, packaging, and project management for OTC and natural health products. Capabilities span solid dose (tablets, capsules, granules, powders), liquid dose (solutions, suspensions, lotions, syrups), and semi-solid dose (creams, ointments, wax-based suppositories), plus tube/jar/suppository filling, specialized labeling and custom display packaging, and concept-to-commercialization support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Trillium Health Care Products company profile →
Crown Laboratories
HQ: United States
Website
- Description: Provider of consumer healthcare products, prescription products, and contract development and manufacturing services as a fully integrated specialty pharmaceutical company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Crown Laboratories company profile →
August Bio
HQ: United States
Website
- Description: Provider of CDMO services, offering expert, collaborative drug discovery, clinical development, and pharmaceutical and clinical manufacturing, with comprehensive support to advance drug discovery, pharmaceutical development, and clinical manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full August Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CHEORS
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CHEORS
2.2 - Growth funds investing in similar companies to CHEORS
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CHEORS
4.2 - Public trading comparable groups for CHEORS
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →